Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Mary Miller

General Counsel at Acrivon Therapeutics, Inc. (ACRV)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $2K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 7SEC ACRVAcrivon Therapeutics, Inc. Sell 29481,715 held (−0%) $1.99 $585 -17.6%
Aug 20SEC ACRVAcrivon Therapeutics, Inc. Sell 18582,009 held (−0%) $2.01 $372 -18.4%
Jul 23SEC ACRVAcrivon Therapeutics, Inc. Sell 57382,194 held (−1%) $1.76 $1K -6.8%